AIG
CLYM

American International Group’s Climb Bio CLYM Stock Holding History

American International Group’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,995
Closed -$25K – 3294
2022
Q1 		$25K Sell
2,995
-755
-20% -$7.04K ﹤0.01% 3000
2021
Q4 		$39K Sell
3,750
-113
-3% -$1.69K ﹤0.01% 3014
2021
Q3 		$69K Buy
+3,863
New +$79.8K ﹤0.01% 2927

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PL
Parkwood LLC Cleveland, Ohio $1.13B AUM 32.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Tudor Investment Corp
Tudor Investment Corp Stamford, Connecticut $53.9B AUM 29.12% 1-Year Est. Return

American International Group's CLYM Position: Q2 2022 in Review

American International Group sold out of Climb Bio (CLYM) in Q2 2022, closing a stake of 2,995 shares — an estimated $25K sold.

American International Group first reported a position in CLYM in Q3 2021 and held it in 3 quarters. The position peaked at $69K in Q3 2021. 29 funds tracked by Wall St. Rank hold CLYM as of Q2 2022.

  • American International Group reported no remaining Climb Bio position as of Q2 2022 after selling out during the quarter.
  • American International Group sold 2,995 Climb Bio shares in Q2 2022, an estimated $25K.
  • American International Group first reported a position in Climb Bio in Q3 2021 and held it in 3 quarters.
  • American International Group's Climb Bio position peaked at $69K in Q3 2021.
  • 29 funds tracked by Wall St. Rank held Climb Bio as of Q2 2022.

Based on American International Group's 13F filing for Q2 2022, filed 12 Aug 2022.